GSK chief warns UK drug pricing reforms threaten industry
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
Category : Search result: Gilead Sciences
Moderna's Oxfordshire vaccine centre gets green light
In a landmark development for UK life sciences, Moderna's cutting-edge mRNA vaccine research centre is coming to Oxfordshire, creating hundreds of jobs and cementing Britain's position in global healthcare innovation.
Six-month HIV prevention jab for 120 countries by 2027
A groundbreaking HIV prevention injection offering six months of protection with lenacapavir will be available in 120 lower-income countries by 2027 through a landmark access agreement.
Trump's Shocking Dismissal of Scientific Evidence Exposed
Exclusive report reveals how Donald Trump repeatedly dismissed crucial scientific evidence from the National Academy of Sciences during his presidency, undermining expert advice on critical policy matters.
AstraZeneca shifts cancer drug production from UK to Ireland
Pharmaceutical giant Merck to manufacture flagship cancer drug Lynparza at new €1 billion Irish facility, dealing significant blow to UK's life sciences sector and raising fresh post-Brexit trade concerns.
Big Pharma's Billion-Pound Bet on Post-Trump UK
Major pharmaceutical giants AstraZeneca, MSD (Merck), and Eli Lilly announce massive new investments in UK research and manufacturing, signalling a major vote of confidence in the British life sciences sector following the US election result.
UK's Top Biology Universities 2025 Revealed
Exclusive analysis of the Guardian's 2025 league table reveals which UK universities are leading in biological sciences. Discover the top performers and rising stars shaping the next generation of biologists.
UK's Best Earth & Marine Sciences Universities 2025
Exclusive guide to the best UK universities for Earth and Marine Sciences. Discover which institutions lead in climate research, oceanography, and environmental science for 2025.
AstraZeneca Pauses £200m Cambridge Research Investment
Pharmaceutical giant AstraZeneca pauses its major £200m Cambridge research centre expansion, citing global strategic review and UK economic uncertainty in post-Brexit landscape.
MSD to create 125+ new R&D jobs in London expansion
Pharmaceutical giant MSD, known as Merck in the US, is significantly expanding its UK presence with a new state-of-the-art research hub in London, generating over 125 new high-skilled jobs and reinforcing the city's status as a global life sciences leader
Pharma Giant Cuts 9,000 Jobs in Major Restructure
A major pharmaceutical multinational has announced a drastic cost-cutting plan, putting 9,000 roles at risk globally. The move signals deepening turmoil within the industry, raising concerns for the UK's strategic life sciences sector.
Aberdeen Three: Animal Activists as Terrorists
The gripping account of the 'Aberdeen Three' animal rights activists whose 1987 lab raid led to unprecedented terrorism charges, a landmark trial, and a seismic shift in UK activism.
EMA approves groundbreaking HIV prevention drug
The European Medicines Agency has approved a groundbreaking HIV prevention drug, marking a significant step forward in public health. Learn more about this medical milestone.
Page 1 of 1